Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study of Integrated Assessment of Amiodarone Effects Based on Clinical Evaluation and Plasma Concentration Control in Patients With Paroxysmal Atrial Fibrillation in Parallel Groups

NCT07487714 is registered in ClinicalTrials.gov with Tomsk National Research Medical Center of the Russian Academy of Sciences as lead sponsor.

NCT NCT07487714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07487714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study of Integrated Assessment of Amiodarone Effects Based on Clinical Evaluation and Plasma Concentration Control in Patients With Paroxysmal Atrial Fibrillation in Parallel Groups
Lead sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
January 12, 2026
Completion date
August 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal af, therapeutic drug monitoring (tdm), treatment decisions